Sherman Chu1,2, Kory P Schrom3, Raghav Tripathi1, Rosalynn R Z Conic4, Harib H Ezaldein1,3, Jeffrey F Scott1,3,5, Kord Honda1,3. 1. Department of Dermatology, Case Western Reserve University, Cleveland, OH. 2. Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Northwest, Lebanon, OR. 3. Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH. 4. Department of Family and Preventive Medicine, University of California San Diego, San Diego, CA; and. 5. Department of Dermatology, Johns Hopkins University, Baltimore, MD.
Abstract
BACKGROUND: Pure and mixed desmoplastic melanomas (DMs) may have different natural histories and behaviors. METHODS: We conducted a retrospective review of patients diagnosed with DM at our institution between January 1997 and April 2019. A total of 33 unique DMs were identified and subsequently analyzed based on the histologic type (pure vs. mixed). RESULTS: The majority (57.6%) of our cases were classified as pure histology. Patients with pure DMs were more likely to be men (P = 0.035) and be older than 65 years (P = 0.019) compared with patients with mixed DMs. Patients with mixed DM were more likely to have mitoses present (P = 0.001) compared with patients with pure DM. There were no differences in ulceration, perineural invasion, vascular invasion, or survival between patients with pure and mixed histologic subtypes. In addition, no differences in sentinel lymph node biopsy, radiation, or chemotherapy were noted between the 2 histologic subtypes. Immunohistochemistry showed that 27.3% of the pure DMs stained with Melan-A and HMB45 were positive for these immunomarkers. CONCLUSIONS: Pure and mixed variants of DM were found to have similar clinicopathologic characteristics. Patients with the mixed histologic subtype were more likely to have mitoses, but no difference in the therapeutic management or patient survival was seen between the 2 subtypes.
BACKGROUND: Pure and mixed desmoplastic melanomas (DMs) may have different natural histories and behaviors. METHODS: We conducted a retrospective review of patients diagnosed with DM at our institution between January 1997 and April 2019. A total of 33 unique DMs were identified and subsequently analyzed based on the histologic type (pure vs. mixed). RESULTS: The majority (57.6%) of our cases were classified as pure histology. Patients with pure DMs were more likely to be men (P = 0.035) and be older than 65 years (P = 0.019) compared with patients with mixed DMs. Patients with mixed DM were more likely to have mitoses present (P = 0.001) compared with patients with pure DM. There were no differences in ulceration, perineural invasion, vascular invasion, or survival between patients with pure and mixed histologic subtypes. In addition, no differences in sentinel lymph node biopsy, radiation, or chemotherapy were noted between the 2 histologic subtypes. Immunohistochemistry showed that 27.3% of the pure DMs stained with Melan-A and HMB45 were positive for these immunomarkers. CONCLUSIONS: Pure and mixed variants of DM were found to have similar clinicopathologic characteristics. Patients with the mixed histologic subtype were more likely to have mitoses, but no difference in the therapeutic management or patient survival was seen between the 2 subtypes.
Authors: Jonathan A Dunne; Justin C R Wormald; Jessica Steele; Elizabeth Woods; Joy Odili; Barry W E M Powell Journal: J Plast Reconstr Aesthet Surg Date: 2016-11-16 Impact factor: 2.740
Authors: Dale Han; Jonathan S Zager; Daohai Yu; Xiuhua Zhao; Brooke Walls; Suroosh S Marzban; Nikhil G Rao; Vernon K Sondak; Jane L Messina Journal: Ann Surg Oncol Date: 2013-02-07 Impact factor: 5.344
Authors: Natalia Jaimes; Lucy Chen; Stephen W Dusza; Cristina Carrera; Susana Puig; Luc Thomas; John W Kelly; Lucy Dang; Iris Zalaudek; Ralph P Braun; Scott W Menzies; Klaus J Busam; Ashfaq A Marghoob Journal: JAMA Dermatol Date: 2013-04 Impact factor: 10.282
Authors: P N Broer; M E Walker; C Goldberg; S Buonocore; D T Braddock; R Lazova; D Narayan; S Ariyan Journal: Eur J Surg Oncol Date: 2013-03-22 Impact factor: 4.424
Authors: Evan George; Susannah E McClain; Craig L Slingluff; Nayak L Polissar; James W Patterson Journal: J Cutan Pathol Date: 2009-04 Impact factor: 1.587
Authors: Zeynep Eroglu; Jesse M Zaretsky; Siwen Hu-Lieskovan; Dae Won Kim; Alain Algazi; Douglas B Johnson; Elizabeth Liniker; Rodrigo Munhoz; Suthee Rapisuwon; Pier Federico Gherardini; Bartosz Chmielowski; Xiaoyan Wang; I Peter Shintaku; Cody Wei; Jeffrey A Sosman; Richard W Joseph; Michael A Postow; Matteo S Carlino; Wen-Jen Hwu; Richard A Scolyer; Jane Messina; Alistair J Cochran; Georgina V Long; Antoni Ribas Journal: Nature Date: 2018-01-10 Impact factor: 49.962